Does Dr. DANIEL DANAHEY have financial conflicts of interest?

Dr. DANIEL DANAHEY (MD, PHD) has received a total of $1,700 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,700 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DANIEL DANAHEY?

According to CMS Open Payments data, Dr. DANIEL DANAHEY received funding from ABBVIE ($722), REGENERON HEALTHCARE SOLUTIONS ($264), and GENZYME CORPORATION ($182).

Does Dr. DANIEL DANAHEY receive research grants or speaking fees?

Dr. DANIEL DANAHEY has received $1,700 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DANIEL DANAHEY

MD, PHDReal-Time Hydrated

Specialty: Otolaryngology, Plastic Surgery within the Head & Neck

Practice Location: GLEN ELLYN, IL 60137

NPI Number: 1063499754

LIFETIME INDUSTRY VALUE

$1,700

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. DANAHEY is a verified Otolaryngology, Plastic Surgery within the Head & Neck practitioner based in GLEN ELLYN, IL.

Between 2021 and 2025, Dr. DANAHEY had an overall industry promotional and research financial footprint of $1,700 as recorded in the federal CMS Open Payments database.

$1,700 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DANAHEY's primary funding source is ABBVIE, which accounts for $722 (representing 42.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$722

42.5%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$264

15.5%

GENZYME CORPORATION

Rank 3

$182

10.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.